No black box warning on record for Guanfacine Er

As of the latest FDA labeling reviewed, Guanfacine Er (GUANFACINE ER) does not carry a black box warning. Standard warnings and precautions still apply — see the full Guanfacine Er medicine page for the complete safety profile.

Other warnings & precautions

5.1 Hypotension, Bradycardia, and Syncope Treatment with guanfacine can cause dose-dependent decreases in blood pressure and heart rate. Decreases were less pronounced over time of treatment. Orthostatic hypotension and syncope have been reported [see Adverse Reactions (6.1)]. Measure heart rate and blood pressure prior to initiation of therapy, following dose increases, and periodically while on

No black box warning on record for Guanfacine Er

Other warnings & precautions

5.1 Hypotension, Bradycardia, and Syncope Treatment with guanfacine can cause dose-dependent decreases in blood pressure and heart rate. Decreases were less pronounced over time of treatment. Orthostatic hypotension and syncope have been reported [see Adverse Reactions (6.1)]. Measure heart rate and blood pressure prior to initiation of therapy, following dose increases, and periodically while on

Guanfacine Er Black Box Warning

No black box warning on record for Guanfacine Er

Other warnings & precautions

Guanfacine Er Black Box Warning

No black box warning on record for Guanfacine Er

Other warnings & precautions